Medical abortion

Association and Non-Governmental Organization resources

Recent Ipas Publications

Ipas, Medical Abortion, Frequently Asked Questions.
Ipas, Can Medical Abortion Be Used in the Second Trimester? (2013).
Ipas, New findings support both outpatient medical abortion up to 10 weeks gestation and home use of mifepristone (2013)
Ipas, Clinical Updates in Reproductive Health, (January 2013). Latest Ipas clinical updates on medication abortion. (Also, available in Spanish.
Ipas, Saving lives, respecting rights.
A dissemination packet for WHO Safe Abortion: Technical and policy guidance for health systems, Second edition (2013). This is an adaptable trainers’ presentation to inform providers, advocates, government officials and colleagues of the updates in the Second edition of Safe abortion: technical and policy guidance for health systems. Fit with trainers’ notes, each slide can be used in entirety for a full training or individual slides for strategic updates.
Ipas, Misoprostol for treatment of incomplete abortions: Training guide (2012).
Ipas, Protocols for medical abortion (2012).
This dosage card serves as a quick reference guide for health-care providers who are administering medical abortion. It includes the regimen for mifepristone and misoprostol for abortion up to nine weeks, as well as 9-13 weeks.
Ipas, Medical abortion and privacy: 5 useful pieces of advice will help concerned women, In Medical Abortion Matters, May 2012.
Ipas, Medical Abortion Supply Guidance Spreadsheet (2011)
A simple supply management tool developed by Ipas that can be successfully used in service delivery settings that use misoprostol for postabortion care (PAC) as well as in settings where both misoprostol for PAC and induced abortion are available. This tool will enable you to quickly and easily calculate your facility's average monthly consumption of misoprostol (and mifepristone, depending on your setting) and recommended minimum and maximum inventory levels. (Also available in Spanish and French).
Ipas, Misoprostol Use in Post Abortion Care: A Service Delivery Toolkit (2011).
Ipas, Is a successful medical abortion different than a complete medical abortion? (February 1, 2011).
Uses of the term ‘successful’ versus ‘complete’ in describing process. All medical abortions are incomplete during some phases of the process, even when the abortions are ultimately successful.

Other Organizations’ Resources

Center for Reproductive Rights
Center for Reproductive Rights. Promote Access to the Full Range of Abortion Technologies: Remove Barriers to Medical Abortion (2005) Center for Reproductive Rights’ and Patent’s shadow letter on Hungary to the CEDAW Committee, 2012.  A shadow letter submitted to the CEDAW committee during its review of Hungary’s compliance with the Convention, raised the issue of lack of availability of medication abortion.  The Committee, however, did not raise the issue in its concluding observations.
Gynuity Health Projects
Gynuity Health Projects, Providing Medical Abortion in Low-Resource Settings:  An Introductory Guidebook (2009). Medical abortion guidebook and tool for providers and policymakers). Available in Arabic, English, French, Portuguese, Romanian, Russian, Spanish, Tamil, Turkish, Vietnamese.
Gynuity Health Projects, Map of Misoprostol Approvals - This map reflects Gynuity’s latest information about the registration of this medication. Available in English, Spanish and Russian.
Gynuity Health Projects generally has lots of resources on medication abortion
International Consortium for Medical Abortion
International Consortium for Medical Abortion, The ICMA Information Package on Medical Abortion.  Information for health care providers.
International Consortium for Medical Abortion, The ICMA Information Package on Medical Abortion.  Information for policy makers.
International Consortium on Medical Abortion (ICMA) has useful resources on medical abortion.
International Planned Parenthood Federation
International Planned Parenthood Federation, First Trimester Abortion Guidelines and Protocols: Surgical and medical procedures (2008). The aim of this document is to integrate protocols, guidelines and standards in a broad framework to ensure that no aspect of care is overlooked when providing comprehensive abortion care in the first trimester of pregnancy.

Professional Associations

International Federation of Gynecology and Obstetrics (FIGO), Ethical Aspects of Induced Abortion for Non-medical Reasons (1998).
Recognizes that medical abortion is safe and recommends that after appropriate counseling, a woman has the right to have access to medical or surgical induced abortion, and that the health care service has an obligation to provide such services as safely as possible.
International Federation of Gynecology and Obstetrics (FIGO), Safe Motherhood (2012)
Where abortion is not against the law, every woman should have the right, after appropriate counseling, to have access to medication or surgical abortion. The health care service has an obligation to provide such services as safely as possible. Proper medical and humane treatment should be made available to women who have undergone an unsafe abortion.
International Federation of Gynecology and Obstetrics (FIGO), Ethical Considerations Respecting the Use of Anti-Progestins (1994).
 As far back as 1994, FIGO has supported the provision of medication abortion. FIGO noted that in countries where anti-progestins have been made available, there is no evidence to suggest that they have increased resort to induced abortion. The method simply provides women with a choice between medical and surgical termination of pregnancy. It also recognized that medical abortion could help prevent unsafe abortion and resulting maternal mortality and morbidity.
Royal College of Obstetricians and Gynaecologists.   The care of women requesting induced abortion (2011).
Medical methods of abortion are effective. Provides clinical guidelines for its administration.